Management of Postmenopausal Osteoporosis

被引:59
作者
Andreopoulou, Panagiota [1 ]
Bockman, Richard S. [1 ,2 ]
机构
[1] Hosp Special Surg, Endocrine Serv, Dept Med, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY 10065 USA
来源
ANNUAL REVIEW OF MEDICINE, VOL 66 | 2015年 / 66卷
关键词
bone microarchitecture; fracture risk; combination therapy; BONE-MINERAL DENSITY; VITAMIN-D SUPPLEMENTATION; PARATHYROID-HORMONE; 1-84; VERTEBRAL FRACTURE RISK; YEARLY ZOLEDRONIC ACID; HIP FRACTURE; NONVERTEBRAL FRACTURES; CAUCASIAN WOMEN; SPINE BMD; SCORE TBS;
D O I
10.1146/annurev-med-070313-022841
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
A hallmark of menopause, which follows the decline in the ovarian production of estrogen, is the aggressive and persistent loss of bone mineral and structural elements leading to loss of bone strength and increased fracture risk. This review focuses on newer methods of diagnosing osteoporosis and assessing fracture risk, as well as on novel management strategies for prevention and treatment. Fracture-risk prediction has been significantly enhanced by the development of methods such as the trabecular bone score, which helps assess bone microarchitecture and adds value to standard bone densitometry, and the Fracture Risk Assessment Tool (FRAX) algorithm techniques. The treatment of osteoporosis, which has the goals of fracture prevention and risk reduction, is moving beyond traditional monotherapies with antiresorptives and anabolic agents into new combination regimens.
引用
收藏
页码:329 / 342
页数:14
相关论文
共 97 条
[1]
Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort Analysis [J].
Abrahamsen, Bo ;
Eiken, Pia ;
Eastell, Richard .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (12) :5258-5265
[2]
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[3]
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures [J].
Austin, Matthew ;
Yang, Yu-Ching ;
Vittinghoff, Eric ;
Adami, Silvano ;
Boonen, Steven ;
Bauer, Douglas C. ;
Bianchi, Gerolamo ;
Bolognese, Michael A. ;
Christiansen, Claus ;
Eastell, Richard ;
Grauer, Andreas ;
Hawkins, Federico ;
Kendler, David L. ;
Oliveri, Beatriz ;
McClung, Michael R. ;
Reid, Ian R. ;
Siris, Ethel S. ;
Zanchetta, Jose ;
Zerbini, Cristiano A. F. ;
Libanati, Cesar ;
Cummings, Steven R. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (03) :687-693
[4]
Oral bisphosphonates are associated with reduced mortality after hip fracture [J].
Beaupre, L. A. ;
Morrish, D. W. ;
Hanley, D. A. ;
Maksymowych, W. P. ;
Bell, N. R. ;
Juby, A. G. ;
Majumdar, S. R. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) :983-991
[5]
Fracture prevention with vitamin D supplementation - A meta-analysis of randomized controlled trials [J].
Bischoff-Ferrari, HA ;
Willett, WC ;
Wong, JB ;
Giovannucci, E ;
Dietrich, T ;
Dawson-Hughes, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (18) :2257-2264
[6]
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].
Black, Dennis M. ;
Delmas, Pierre D. ;
Eastell, Richard ;
Reid, Ian R. ;
Boonen, Steven ;
Cauley, Jane A. ;
Cosman, Felicia ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Mautalen, Carlos ;
Mesenbrink, Peter ;
Hu, Huilin ;
Caminis, John ;
Tong, Karen ;
Rosario-Jansen, Theresa ;
Krasnow, Joel ;
Hue, Trisha F. ;
Sellmeyer, Deborah ;
Eriksen, Erik Fink ;
Cummings, Steven R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822
[7]
Continuing Bisphosphonate Treatment for Osteoporosis - For Whom and for How Long? [J].
Black, Dennis M. ;
Bauer, Douglas C. ;
Schwartz, Ann V. ;
Cummings, Steven R. ;
Rosen, Clifford J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (22) :2051-2053
[8]
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [J].
Black, Dennis M. ;
Reid, Ian R. ;
Boonen, Steven ;
Bucci-Rechtweg, Christina ;
Cauley, Jane A. ;
Cosman, Felicia ;
Cummings, Steven R. ;
Hue, Trisha F. ;
Lippuner, Kurt ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Martinez, Ruvie Lou Maria ;
Tan, Monique ;
Ruzycky, Mary Ellen ;
Su, Guoqin ;
Eastell, Richard .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :243-254
[9]
Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur [J].
Black, Dennis M. ;
Kelly, Michael P. ;
Genant, Harry K. ;
Palermo, Lisa ;
Eastell, Richard ;
Bucci-Rechtweg, Christina ;
Cauley, Jane ;
Leung, Ping Chung ;
Boonen, Steven ;
Santora, Arthur ;
de Papp, Anne ;
Bauer, Douglas C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (19) :1761-1771
[10]
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938